0907 ET - Investors have been shying away from Jamieson Wellness as they look for the safer haven of larger cap companies, but TD Cowen's Derek Lessard thinks the pullback is unwarranted. So far in the year, the stock has pulled back 15% to C$31.11, nearly wiping out the gains of the past 52 weeks. But there are plenty of positives to drive the stock, including strong contributions from the Chinese market. "With no negative operational news, our positive outlook on 4Q and longer-term is unchanged," he says in a report. The fundamentals are the same, and with the stock down, it "makes the pullback an attractive buying opportunity." (adriano.marchese@wsj.com)
(END) Dow Jones Newswires
February 10, 2025 09:07 ET (14:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.